Relevance of nonsurgical periodontal treatment on hemoglobin A1c level in patients with Type 2 Diabetes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011908

Enrollment

100

Registered

2026-04-27

Start date

2025-07-24

Completion date

Unknown

Last updated

2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The inclusion and exclusion criteria for the study participants are identical for both groups, as are the number of visits and the methods for efficacy assessment. The experimental

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals aged 30 or older with periodontal disease Individuals diagnosed with Type 2 diabetes (HbA1c = 6.5%) Patients without major diabetic complications Individuals managed with oral hypoglycemic agents (excluding those on direct insulin therapy) Individuals with no history of systemic antibiotic administration or periodontal treatment within the past 3 months

Exclusion criteria

Exclusion criteria: Users of immunosuppressants, steroids, hydantoin, or non-steroidal anti-inflammatory drugs (NSAIDs) Pregnant women Individuals with fixed orthodontic appliances Those who refuse or fail to provide informed consent Individuals aged 29 or younger

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
Reductions in Probing Pocket DepthLevel ;Reductions in Clinical Attachment ;Plaque index ;Bleeding on Probing	—

Countries

Korea, Republic of

Contacts

Public ContactYejun Park

Chung-Ang University Gwangmyeong Hospital

yj03245@naver.com+82-2-2610-6694

Outcome results